Actively Recruiting
Evaluating Endoscopic Duodenal Recellularization Therapy Using Pulsed Electric Field as Early Treatment for Type 2 Diabetes Mellitus
Led by Chinese University of Hong Kong · Updated on 2026-09-15
40
Participants Needed
1
Research Sites
78 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the safety and effectiveness of a new treatment called endoscopic duodenal re-cellularization therapy using pulsed electric field in adults recently diagnosed with type 2 diabetes mellitus T2DM. This feasibility study focuses on individuals with a recent T2DM diagnosis to understand how well this treatment works early in the disease course. Participants will undergo the pulsENDO procedure, which involves using a catheter inserted through the mouth to deliver pulsed electric fields to the duodenum, targeting 10 to 18 centimeters of its length. This treatment aims to stimulate cell regeneration by ablating the duodenal mucosa with irreversible electroporation under endoscopic guidance. The study is single-group, with all participants receiving this experimental procedure. After the procedure, participants will be followed closely for six months to assess the primary outcome of maintaining HbA1c levels at or below 6.5% without glucose-lowering drugs. Follow-up continues up to two years to monitor additional outcomes such as body weight, body fat, liver health, quality of life, and any adverse events. The study involves periodic clinical assessments and safety monitoring to track the effects and durability of the treatment over time.
CONDITIONS
Brief Title
Duodenal pulsENDO as an Early Treatment for Type 2 DM
Research Team
S
Stephen Ng, FRCSEd(Gen)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here